City of Hope has implemented a policy to comply with current ACCME Standards of Commercial Support requiring resolution of all faculty conflicts of interest. Prior to their participation in this activity all faculty have disclosed any real or apparent vested commercial interest(s) in both those companies whose products may be discussed/described during the course of the activity and in those companies who may be acting as commercial supporters of the activity.
City of Hope has further required that prior to the activity faculty have disclosed their intention to discuss any off-label and/or investigational (not yet approved for any purpose) use of pharmaceuticals or medical devices.
Disclosure of faculty specific commercial relationships and/or intent to discuss “off-label” and/or investigational use is as follows:
The following faculty have indicated that they have no relationship that, in the context of the educational content of this activity could be perceived as a potential conflict of interest: Dr. James Ito, Dr. Sanjeet Dadwal, Dr. Bernie Tegtmeier and Annemarie Flood, RN, CIC.
Discussion of Off-Label/Investigational Uses of Commercial Products:
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the FDA and/or other national regulatory agencies of the United States and other countries. Participants in the United States are encouraged to consult the FDA-approved product labeling for any drug or device mentioned in the program before use. Participants from other countries should consult with their respective regulatory authorities.